Process View
Any process that activates or increases the frequency, rate or extent of ligase activity, the catalysis of the ligation of two substances with concomitant breaking of a diphosphate linkage, usually in a nucleoside triphosphate.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of ligase activity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RING1 | ring finger protein 1 | 0.958 | ||
| RNF2 | ring finger protein 2 | 0.910 | ||
| CBX8 | chromobox homolog 8 | 0.875 | ||
| BMI1 | BMI1 polycomb ring finger oncogene | 0.828 | ||
| CDC27 | cell division cycle 27 homolog (S. cerevisiae) | 0.729 | ||
| UBE2V1 | ubiquitin-conjugating enzyme E2 variant 1 | 0.673 | ||
| CBX7 | chromobox homolog 7 | 0.589 | ||
| SIRT2 | sirtuin 2 | 0.448 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.390 | ||
| ARIH2 | ariadne homolog 2 (Drosophila) | 0.341 | ||
| CTAG1B | cancer/testis antigen 1B | 0.259 | ||
| NAP1L5 | nucleosome assembly protein 1-like 5 | 0.205 | ||
| TEKT4 | tektin 4 | 0.180 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.178 | ||
| CBX6 | chromobox homolog 6 | 0.163 | ||
| RNF144B | ring finger protein 144B | 0.159 | ||
| PJA1 | praja ring finger 1 | 0.140 | ||
| EID2 | EP300 interacting inhibitor of differentiation 2 | 0.139 | ||
| PLK1 | polo-like kinase 1 | 0.124 | ||
| FHL1 | four and a half LIM domains 1 | 0.123 | ||
| UBE3A | ubiquitin protein ligase E3A | 0.119 | ||
| FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.101 | ||
| CBX4 | chromobox homolog 4 | 0.097 | ||
| USP11 | ubiquitin specific peptidase 11 | 0.091 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.083 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.082 | ||
| EID2B | EP300 interacting inhibitor of differentiation 2B | 0.079 | ||
| MAGEA1 | melanoma antigen family A, 1 (directs expression of antigen MZ2-E) | 0.071 | Human | |
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.061 | ||
| RYBP | RING1 and YY1 binding protein | 0.061 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.060 | ||
| AMMECR1 | Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 | 0.060 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.059 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.058 | ||
| MAGEA12 | melanoma antigen family A, 12 | 0.058 | Human | |
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.056 | ||
| ATF5 | activating transcription factor 5 | 0.048 | ||
| ADRB2 | adrenergic, beta-2-, receptor, surface | 0.048 | ||
| RNF11 | ring finger protein 11 | 0.046 | ||
| MAGEA3 | melanoma antigen family A, 3 | 0.045 | ||
| LNX1 | ligand of numb-protein X 1 | 0.044 | ||
| MAGEA6 | melanoma antigen family A, 6 | 0.044 | Human | |
| BCOR | BCL6 corepressor | 0.043 | ||
| GCLC | glutamate-cysteine ligase, catalytic subunit | 0.042 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.039 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.037 | ||
| PRNP | prion protein | 0.037 | ||
| APLF | aprataxin and PNKP like factor | 0.037 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.036 | ||
| MAGEA5 | melanoma antigen family A, 5 | 0.036 | ||
| BAX | BCL2-associated X protein | 0.035 | ||
| EID3 | EP300 interacting inhibitor of differentiation 3 | 0.035 | ||
| UBE2M | ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) | 0.033 | ||
| LIG4 | ligase IV, DNA, ATP-dependent | 0.031 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.031 | ||
| PCGF1 | polycomb group ring finger 1 | 0.030 | Human | |
| CLSPN | claspin | 0.030 | ||
| DAXX | death-domain associated protein | 0.030 | ||
| TRIM69 | tripartite motif containing 69 | 0.029 | ||
| KAT5 | K(lysine) acetyltransferase 5 | 0.029 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.028 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.026 | ||
| PCGF5 | polycomb group ring finger 5 | 0.025 | Human | |
| NRIP1 | nuclear receptor interacting protein 1 | 0.025 | ||
| TUBB2C | tubulin, beta 2C | 0.025 | ||
| SUFU | suppressor of fused homolog (Drosophila) | 0.024 | ||
| PML | promyelocytic leukemia | 0.022 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.022 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.022 | ||
| TRIM28 | tripartite motif containing 28 | 0.022 | ||
| MOAP1 | modulator of apoptosis 1 | 0.020 | ||
| MAGEA2 | melanoma antigen family A, 2 | 0.020 | ||
| MAK | male germ cell-associated kinase | 0.020 | ||
| MAGEC1 | melanoma antigen family C, 1 | 0.020 | Human | |
| EID1 | EP300 interacting inhibitor of differentiation 1 | 0.019 | ||
| PCGF3 | polycomb group ring finger 3 | 0.019 | Human | |
| PCGF2 | polycomb group ring finger 2 | 0.018 | Human | |
| EIF2S2 | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | 0.018 | ||
| POLR2C | polymerase (RNA) II (DNA directed) polypeptide C, 33kDa | 0.017 | ||
| PSMA3 | proteasome (prosome, macropain) subunit, alpha type, 3 | 0.017 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.017 | ||
| UBE2L3 | ubiquitin-conjugating enzyme E2L 3 | 0.016 | ||
| YAF2 | YY1 associated factor 2 | 0.016 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.016 | ||
| GET4 | golgi to ER traffic protein 4 homolog (S. cerevisiae) | 0.015 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.015 | ||
| ERH | enhancer of rudimentary homolog (Drosophila) | 0.015 | ||
| RBX1 | ring-box 1, E3 ubiquitin protein ligase | 0.015 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.015 | ||
| CSNK2B | casein kinase 2, beta polypeptide | 0.015 | ||
| RANGAP1 | Ran GTPase activating protein 1 | 0.014 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.014 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.014 | ||
| NHEJ1 | nonhomologous end-joining factor 1 | 0.014 | ||
| HSPA1L | heat shock 70kDa protein 1-like | 0.014 | ||
| TUBG1 | tubulin, gamma 1 | 0.014 | ||
| MAGEA4 | melanoma antigen family A, 4 | 0.013 | Human | |
| DEAF1 | deformed epidermal autoregulatory factor 1 (Drosophila) | 0.013 | ||
| PTTG1 | pituitary tumor-transforming 1 | 0.013 | ||
| MAGEB2 | melanoma antigen family B, 2 | 0.012 | Human | |
| RNF31 | ring finger protein 31 | 0.012 | ||
| MAD2L1 | MAD2 mitotic arrest deficient-like 1 (yeast) | 0.012 | ||
| CDC25C | cell division cycle 25 homolog C (S. pombe) | 0.012 | ||
| DVL2 | dishevelled, dsh homolog 2 (Drosophila) | 0.012 | ||
| TADA3 | transcriptional adaptor 3 | 0.012 | ||
| ANAPC11 | anaphase promoting complex subunit 11 | 0.011 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.011 | ||
| MAGEC2 | melanoma antigen family C, 2 | 0.011 | ||
| CTAG2 | cancer/testis antigen 2 | 0.011 | ||
| CUL4A | cullin 4A | 0.011 | ||
| CDKN2AIP | CDKN2A interacting protein | 0.011 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.010 | ||
| KRT15 | keratin 15 | 0.010 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.010 |